OakChart

Inmode Ltd

INMDHealthcare·Medical Devices·Israel·Small·NASD·Nov 11 • 3:59 PM ET

13.73+0.46 (3.51%)
2026-11-11 21:59 CET
Market cap
763.32 USD m
Revenue, TTM
374.62 USD m
Net income, TTM
77.51 USD m
Free cash flow, TTM
88.40 USD m
EPS diluted, TTM
1.23
P/E
11.14
Compare

Price

INMD against its 20, 50 and 200-day averages
2050200beatearnings
13.0014.0015.001.7M3.5MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26INMDclose 13.7320-day 13.7750-day 14.16200-day 14.3013.73

17.6% under the 52-week high of 16.67 on 2 Feb 2026. 52-week low 12.72 on 12 Mar 2026. Last 15 sessions, 11.2% high to low

Volume 1.68× normal · the line is the 50-bar volume average

Profile

INMD
52-week range, 26% of the way up
12.7216.67

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Employees660
IPOAug 08, 2019
Beta1.96
ATR, 14d0.37
Rel volume1.68
Short float4.72%
Insider own16.37%
Inst own52.30%

Snapshot

6 groups

Valuation

Index-
Market Cap790.08M
Enterprise Value293.41M
Income77.51M
Sales374.62M
Book/sh10.95
Cash/sh8.71
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees660
IPOAug 08, 2019

Ratios

P/E11.14
Forward P/E9.94
PEG-
P/S2.11
P/B1.25
P/C1.58
P/FCF8.94
EV/EBITDA4.20
EV/Sales0.78
Quick Ratio7.28
Current Ratio8.18
Debt/Eq0.01
LT Debt/Eq0.01
Option/ShortYes / Yes

Earnings

EPS (ttm)1.23
EPS next Y1.38
EPS next Q0.37
EPS this Y-17.87%
EPS next Y5.13%
EPS next 5Y-3.14%
EPS past 3/5Y-9.87% 6.62%
Sales past 3/5Y-6.57% 12.44%
EPS Y/Y TTM-50.25%
Sales Y/Y TTM-6.71%
EPS Q/Q-31.60%
Sales Q/Q-0.01%
EarningsNov 11 BMO
EPS/Sales Surpr.15.12% 0.61%

Ownership

Insider Own16.37%
Insider Trans0.00%
Inst Own52.30%
Inst Trans-3.80%
ROA10.85%
ROE12.33%
ROIC12.23%
Gross Margin76.52%
Oper. Margin18.47%
Profit Margin20.69%
SMA20-0.27%
SMA50-3.06%
SMA200-4.00%
Trades-

Technical

Shs Outstand57.48M
Shs Float48.12M
Short Float4.72%
Short Ratio4.56
Short Interest2.27M
52W High16.67 -17.64%
52W Low12.72 7.94%
Volatility3.66% 2.35%
ATR (14)0.37
RSI (14)48.08
Beta1.96
Rel Volume1.68
Avg Volume497.62K
Volume835,152

Performance

Perf Week-3.31%
Perf Month-4.02%
Perf Quarter-9.67%
Perf Half Y-2.21%
Perf YTD-6.54%
Perf Year-5.38%
Perf 3Y-29.59%
Perf 5Y-85.27%
Perf 10Y-
Recom3.00
Target Price16.17
Prev Close13.27
Price13.73
Change %3.51%

Analyst ratings

latest 10 of 16
DateActionAnalystRating changeTargetImplied
Apr 29, 2025DowngradeBBTIG ResearchBuy → Neutral
Apr 28, 2025DowngradeRRobert W. BairdOutperform → Neutral$22 → $16+16.5%
Oct 17, 2024InitiatedBBTIG ResearchBuy$25+82.1%
Jul 23, 2024DowngradeJJefferiesBuy → Hold$21 → $19+38.4%
Nov 03, 2023DowngradeUUBSBuy → Neutral$52 → $24+74.8%
Oct 13, 2023DowngradeCCanaccord GenuityBuy → Hold$55 → $22+60.2%
Mar 29, 2023InitiatedUUBSBuy$40+191.3%
Feb 17, 2023DowngradeNNeedhamBuy → Hold
Dec 21, 2022InitiatedBBarclaysOverweight$44+220.5%
Oct 12, 2022InitiatedJJefferiesBuy$40+191.3%

Peers

Mkt cap
TickerCompanyMkt cap
APYXApyx Medical Corp126.37M
ESTAEstablishment Labs Holdings Inc2.11B
BHCBausch Health Companies Inc3.12B
CNMDConmed Corp1.51B
EOLSEvolus Inc490.12M
ABBVAbbvie Inc521.43B
SRTSSensus Healthcare Inc55.31M
SKINSkinHealth Systems Inc108.08M
IRIXIRIDEX Corp11.47M
AIRSAirsculpt Technologies Inc60.04M

Held by

AUM
TickerCompanyAUM
IEFAiShares Core MSCI EAFE ETFAUM: 191.66B
SCZiShares MSCI EAFE Small-Cap ETFAUM: 12.92B
IXUSiShares Core MSCI Total International Stock ETFAUM: 57.59B
IZRLARK Israel Innovative Technology ETFAUM: 118.95M
EISiShares MSCI Israel ETFAUM: 830.45M
IDEViShares Core MSCI International Developed Markets ETFAUM: 34.12B
FNDCSchwab Fundamental International Small Equity ETFAUM: 3.05B
ITEQAmplify BlueStar Israel Technology ETFAUM: 97.54M
SEISSEI Select Small Cap ETFAUM: 626.66M
GWXState Street SPDR S&P International Small Cap ETFAUM: 906.57M

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-110.3700.3210.32092.1491.585
2026Q22026-08-050.3500.3460.28795.5994.895
2026Q12026-05-060.2500.2980.18182.0279.846
2025Q42026-02-100.4600.4170.422103.85101.727
2025Q32025-11-050.3800.3550.34293.1790.527
2025Q22025-07-300.4700.4110.42095.6097.117
2025Q12025-04-280.3100.3540.26277.8777.537
2024Q42025-02-040.4200.5281.13797.85109.137
2024Q32024-10-300.7000.5670.649130.23126.527
2024Q22024-08-010.3400.3820.27786.45104.816
2024Q12024-05-020.3200.4320.27680.2891.416
2023Q42024-02-130.7100.6570.643126.78124.776
2023Q32023-11-020.6100.6410.541123.11131.266
2023Q22023-07-270.7200.6510.651136.08132.556
2023Q12023-05-020.5200.4680.474106.07101.446
2022Q42023-02-140.7800.6660.437133.57129.695

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY0.8000.7600.803156.36151.86
2020FY1.0550.8870.891206.11201.68
2021FY2.0501.9831.918357.57352
2022FY2.4202.3151.891454.27450.39
2023FY2.5702.5162.303492.05490.13
2024FY1.7601.8642.249394.82406.09
2025FY1.6001.5721.430370.5368.26
2026FY-1.314--370.89
2027FY-1.382--378.59
2028FY-1.454--388.66

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-11500101.1499.42103.85
2026Q4S2026-10-19500101.1499.42103.85
2026Q4S2026-10-12503101.1499.42103.85
2026Q4S2026-10-09503101.1399.42103.85
2026Q4S2026-09-23503101.1299.42103.8
2026Q4S2026-08-21504101.1299.42103.8
2026Q4S2026-08-13504101.1299.42103.8
2026Q4S2026-08-05504101.2899.42103.8
2026Q4S2026-07-20501103.47100.49107.4
2026Q4S2026-07-13505103.47100.49107.4
2026Q4S2026-07-10505103.46100.49107.4
2026Q4S2026-07-08504103.76100.49107.42
2026Q4S2026-06-23504103.76100.49107.42
2026Q4S2026-06-22504103.76100.49107.42

Estimate history

EPS, annual0.1350.3420.8030.8911.9181.8912.3032.2491.4341.2322
Period201720182019202020212022202320242025TTM
EPS, quarterly0.2770.6491.1370.2620.420.3420.4220.1810.287
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual53.456100.162156.361206.107357.565454.271492.048394.818370.495374.62
Period201720182019202020212022202320242025TTM
Sales, quarterly86.449130.23297.85377.87495.60293.165103.85482.01795.589
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual65.44765.44765.59875.56882.97882.54583.98269.55963.35957.481
Period201720182019202020212022202320242025MRQ
Shares, quarterly84.61984.61969.55969.55969.55969.55963.35963.35957.481
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue374.62370.50394.82492.05454.27357.56206.11156.36100.16
Cost of Goods Sold Incl. D&A87.9579.5377.7580.7173.4953.5930.8520.2415.06
Gross Profit286.68290.97317.07411.34380.79303.97175.26136.1285.11
Selling, General and Administrative Excl. Other217.48205.58204.54215.68182.93137.30102.4276.5153.62
Research and Development14.2513.3213.1413.4112.439.539.475.704.18
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income69.2085.39112.53195.66197.85166.6872.8459.6231.49
Unusual Expense0.000.000.000.000.000.000.000.00-
Net Income Before Taxes90.95110.33143.47217.27201.47168.0076.1362.0423.63
Income Taxes13.4416.50-37.8119.3539.952.931.110.881.26
Consolidated Net Income77.5193.83181.28197.92161.52165.0775.0361.1622.37
Net Income From Continuing Operations77.5193.83181.28197.92161.52164.9775.0361.1522.37
Net Income77.5193.83181.28197.92161.52164.9775.0361.1522.37
EPS (Recurring)1.311.432.252.301.891.920.890.800.34
EPS (Basic, Before Extraordinaries)1.241.452.292.371.962.031.041.050.34
EPS (Diluted)1.231.432.252.301.891.920.890.800.34
EBITDA69.8986.08113.26196.28198.53167.1973.2659.9231.67
Non-Operating Income (Expense)21.7524.9430.9421.613.611.333.292.42-7.86
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense7.308.7913.0918.1718.839.212.271.201.48
Price To Earnings Ratio10.7710.779.0310.2616.7235.0123.2719.50-
Price To Sales Ratio2.322.593.413.896.7116.989.709.54-
Gross Margin76.5278.5480.3183.6083.8285.0185.0387.0684.97
Operating Margin18.4723.0528.5039.7643.5546.6135.3438.1331.44
Net Margin20.6925.3345.9140.2235.5646.1436.4039.1122.33
Shares Outstanding57.4863.3669.5683.9882.5482.9875.5765.6065.45
Market Capitalization763.32763.321,413.141,851.072,966.005,391.021,793.971,285.721,231.64

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q4
Total Revenue95.5982.02103.8593.1795.6077.8797.85130.23
Cost of Goods Sold Incl. D&A24.0720.4722.5520.8619.1516.9620.2224.05
Gross Profit71.5261.5581.3072.3176.4560.9177.64106.18
Selling, General and Administrative Excl. Other59.2651.5055.3151.4153.5745.2949.7757.92
Research and Development3.663.543.513.543.372.902.673.25
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income12.2610.0625.9920.9022.8815.6227.8648.26
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes19.6914.3531.2925.6230.9422.4832.2158.18
Income Taxes2.632.794.273.764.204.28-50.567.19
Consolidated Net Income17.0611.5627.0321.8626.7418.2082.7750.99
Net Income From Continuing Operations17.0611.5627.0321.8626.7418.2082.7750.99
Net Income17.0611.5627.0321.8626.7418.2082.7750.99
EPS (Recurring)0.290.180.420.340.420.261.140.65
EPS (Basic, Before Extraordinaries)0.290.180.430.350.420.261.150.66
EPS (Diluted)0.290.180.420.340.420.261.140.65
EBITDA12.4410.2326.1621.0523.0715.7928.1148.40
Non-Operating Income (Expense)7.434.305.304.728.066.864.359.92
Other After Tax Adjustments0.000.000.000.000.000.000.00-
Stock Option Compensation Expense2.962.13-0.472.672.681.992.723.14
Price To Earnings Ratio10.779.466.806.046.217.589.039.23
Price To Sales Ratio2.322.332.542.612.293.143.083.29
Gross Margin74.8275.0578.2877.6179.9778.2279.3481.53
Operating Margin12.8212.2625.0322.4323.9320.0628.4837.06
Net Margin17.8514.1026.0223.4727.9723.3784.5939.15
Shares Outstanding57.4863.3663.3669.5669.5669.5669.5684.62
Market Capitalization763.32866.75928.541,036.421,004.431,233.971,413.141,445.29

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments555.33596.47741.61547.38415.91260.53193.3661.3025.04
Short Term Receivables49.2841.0543.6328.2724.7714.0710.449.507.07
Inventories89.3774.5157.0551.8028.2314.989.416.965.04
Other Current Assets4.632.423.041.931.20----
Total Current Assets698.62714.45845.33629.37470.11289.59213.2177.7637.15
Net Property, Plant & Equipment10.8711.0512.087.375.722.132.300.540.35
Total Investments and Advances0.700.700.700.600.600.600.600.000.00
Long-Term Note Receivable3.003.183.673.970.773.370.370.541.14
Intangible Assets0.000.000.000.000.000.000.000.000.00
Deferred Tax Assets53.2356.281.513.091.330.061.901.310.81
Other Assets0.000.000.000.000.000.000.000.900.00
Total Assets766.43785.67863.29644.41478.54295.76218.3881.0639.44
Short Term Debt Incl. Current Port. of LT Debt3.222.512.401.451.210.880.670.000.00
Accounts Payable17.9113.7813.9716.248.786.413.704.513.06
Income Tax Payable0.760.931.9219.241.240.760.200.321.02
Other Current Liabilities48.8552.6245.8545.0840.6226.9827.9224.609.37
Total Current Liabilities70.7469.8564.1482.0251.8535.0332.4929.4313.46
Long Term Debt5.015.316.613.513.310.360.740.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities------0.040.010.11
Other Liabilities7.486.695.174.267.584.905.314.753.36
Total Liabilities83.2381.8575.9189.7962.7440.2938.5834.1916.92
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity683.20703.81787.37554.62415.80253.96176.0743.2619.45
Total Shareholders Equity683.20703.81787.37554.62415.80253.96176.0743.2619.45
Accumulated Minority Interest0.000.000.000.000.001.513.743.603.07
Total Equity683.20703.81787.37554.62415.80255.47179.8046.8622.52
Total Liabilities & Stockholders Equity766.43785.67863.29644.41478.54295.76218.3881.0639.44
Book Value Per Share10.7810.129.386.725.013.362.680.660.30
Tangible Book Value Per Share10.7810.129.386.725.013.362.680.660.30
Full-Time Employees660599581480362311251189125
Price to Book Ratio1.211.922.565.8414.097.067.307.68-
Return on Assets12.0921.9926.2528.7742.6129.1940.8437.13-
Return on Equity13.5324.3129.5033.2949.2634.9055.7671.34-
Return on Invested Capital13.6325.5624.9328.9439.3629.5034.5851.7145.33
Quick Ratio8.619.1612.297.048.527.846.272.412.39
Current Ratio9.8810.2313.187.679.078.276.562.642.76

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income83.7593.83181.28197.92161.52165.0775.0361.1622.37
Depreciation0.730.700.730.620.680.520.420.300.18
Other Funds (Non Cash)17.6912.1012.9119.9123.7613.8812.670.8010.14
Funds from Operations104.45109.55139.73218.26186.05178.7089.8461.6732.10
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-14.93-24.30-7.07-41.44-4.47-3.81-10.610.544.79
Cash from Operating Activities89.5285.26132.66176.83181.58174.8979.2362.2136.89
Capital Expenditures-1.12-0.97-0.67-0.71-1.58-0.94-0.46-0.69-0.38
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments201.22187.00162.88-135.36-107.90-159.17-42.84-111.76-29.36
Purchase of Investments-470.69-313.51-504.41-478.68-262.38-346.92-225.39-213.83-48.35
Sale Or Maturity of Investments671.91500.52667.28343.32154.48187.76182.55102.0718.99
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities200.10186.03162.21-136.06-109.47-160.11-43.31-112.45-29.74
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-96.08-126.06-282.775.50-41.09-15.02-12.4470.170.19
Repurchase of Common Pref Stock-97.19-127.44-285.390.00-42.64-35.37-17.220.000.00
Sale of Common Pref Stock1.121.392.615.501.5520.344.7870.170.19
Proceedsfrom Stock Options0.000.000.000.000.000.000.0069.780.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow-1.850.000.000.000.000.000.000.000.00
Other Financing Activities Uses-1.850.000.000.000.000.000.000.000.00
Cash from Financing Activities-97.92-126.06-282.775.50-41.09-15.02-12.4470.170.19
Exchange Rate Effect-0.691.98-1.180.61-1.62-0.560.730.08-0.21
Net Change in Cash191.01147.2110.9246.8729.40-0.8024.2120.017.13
Free Cash Flow88.4084.28132.00176.12180.00173.9578.7661.5136.51
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow9.8211.4110.2010.8516.9434.9025.3724.25-
Deferred Taxes & Investment Tax Credit-2.93-55.18-0.180.08-0.771.73-0.59-0.59

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments501.12537.16555.33532.31510.68512.92
Short Term Receivables44.5540.7049.2838.0935.6557.93
Inventories71.6671.4189.3771.4068.1163.78
Other Current Assets32.6631.514.6324.4824.33-
Total Current Assets650.00680.78698.62666.29638.78634.64
Net Property, Plant & Equipment11.3211.2310.8711.1611.5611.37
Total Investments and Advances0.700.700.700.700.700.70
Intangible Assets0.000.000.000.000.000.00
Deferred Tax Assets52.6352.9253.2354.1054.7655.34
Other Assets0.000.000.000.000.000.00
Total Assets720.33750.84766.43734.61708.35704.74
Short Term Debt Incl. Current Port. of LT Debt0.000.003.220.000.000.00
Accounts Payable18.7916.8517.9116.7217.4815.05
Income Tax Payable--0.76---
Other Current Liabilities60.6560.5048.8551.6149.0557.61
Total Current Liabilities79.4477.3570.7468.3366.5372.66
Long Term Debt4.454.835.015.596.105.59
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities7.317.407.487.307.277.06
Total Liabilities91.2089.5883.2381.2279.9185.31
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity629.13661.25683.20653.38628.44619.43
Total Shareholders Equity629.13661.25683.20653.38628.44619.43
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity629.13661.25683.20653.38628.44619.43
Total Liabilities & Stockholders Equity720.33750.84766.43734.61708.35704.74
Book Value Per Share10.9510.4410.789.399.038.91
Tangible Book Value Per Share10.9510.4410.789.399.038.91
Full-Time Employees--660---
Price to Book Ratio1.211.271.561.651.621.75
Return on Assets10.8511.9812.0919.1922.7922.02
Return on Equity12.3313.6213.5321.5225.9124.50
Return on Invested Capital2.691.743.933.324.212.91
Quick Ratio7.287.888.618.718.587.86
Current Ratio8.188.809.889.759.608.73

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income17.8011.5629.6624.7226.9318.20
Depreciation0.190.180.190.180.190.17
Other Funds (Non Cash)5.043.942.316.403.270.85
Funds from Operations23.3416.0133.1131.9930.9720.12
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.35-0.62-8.12-4.83-6.74-6.08
Cash from Operating Activities21.9915.3924.9927.1624.2314.04
Capital Expenditures-0.22-0.17-0.57-0.15-0.22-0.09
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments41.67109.2831.8318.4572.4975.57
Purchase of Investments-89.61-94.64-123.62-162.83-25.19-20.88
Sale Or Maturity of Investments131.28203.91155.44181.2897.6896.45
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities41.45109.1031.2518.3072.2775.49
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-58.73-30.62-1.75-4.98-27.51-99.47
Repurchase of Common Pref Stock-58.76-31.24-1.91-5.28-28.02-99.96
Sale of Common Pref Stock0.040.620.160.300.510.49
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.05-1.800.000.000.000.00
Other Financing Activities Uses-0.05-1.800.000.000.000.00
Cash from Financing Activities-58.77-32.43-1.75-4.98-27.51-99.47
Exchange Rate Effect-0.38-0.310.11-0.111.550.56
Net Change in Cash4.2891.7554.6040.3870.54-9.38
Free Cash Flow21.7715.2124.4127.0124.0113.96
Price to Free Cash Flow9.829.6510.539.768.7810.10

Revenue breakdown

Capital Equipment2024: 315.55M 2025: 289.12M
Consumables And Service Revenues2024: 79.27M 2025: 81.38M
Asia2024: 42.97M 2025: 49.21M
Europe2024: 63.44M 2025: 79.05M
Israel2024: 3.75M 2025: 3.40M
Other countries2024: 39.88M 2025: 40.19M
United States2024: 244.77M 2025: 198.65M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.72%2.3M48.1M465.34K
2026-10-154.61%2.2M48.1M485.54K
2026-09-304.68%2.3M48.1M518.82K
2026-09-154.91%2.4M48.1M613.19K
2026-08-314.89%2.3M48.1M612.07K
2026-08-145.06%2.4M48.1M726.75K
2026-07-314.86%2.3M48.1M831.57K
2026-07-156.22%3.0M48.1M827.18K
2026-06-306.01%2.9M49.0M839.08K
2026-06-156.08%3.3M54.0M867.57K
2026-05-295.30%2.9M54.0M928.85K
2026-05-155.69%3.1M54.0M906.98K
2026-04-306.00%3.3M55.1M1.00M
2026-04-155.90%3.2M55.1M1.13M
2026-03-316.32%3.5M55.9M1.14M
2026-03-135.90%3.3M55.9M1.01M
2026-02-275.07%2.8M55.9M938.62K
2026-02-135.95%3.3M55.9M888.02K
2026-01-305.85%3.3M56.5M716.87K
2026-01-155.66%3.2M56.5M610.64K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call5.006.6010.100.009.0600.000.000.984-0.0170.001
call6.006.109.500.008.7260.000.000.981-0.0170.001
call7.004.608.500.007.4480.000.000.977-0.0160.001
call8.003.607.505.676.3891.000.000.972-0.0160.001
call9.002.656.500.005.4800.000.000.966-0.0150.002
call10.002.155.504.644.7002900.000.957-0.0150.002
call11.001.304.500.004.0210.000.000.912-0.0220.003
call12.000.503.501.453.2575.000.000.830-0.0300.005
call13.000.002.701.812.8305.000.000.644-0.0580.008
call14.000.300.500.300.7204736.000.462-0.0370.008
call15.000.000.200.100.5898,3426.000.159-0.0170.005
call16.000.000.150.060.9352,2232.000.154-0.0270.005
call17.000.000.050.051.0965120.000.098-0.0220.004
call18.000.000.050.031.2821400.000.087-0.0240.003
call19.000.000.050.051.45210.000.000.079-0.0250.003
call20.000.001.000.051.5732.000.000.072-0.0240.003
call21.000.002.150.281.5044.000.000.042-0.0160.002
call22.000.002.150.001.6160.000.000.039-0.0170.002
call25.000.002.150.002.2200.000.000.056-0.0300.002
put5.000.000.050.003.1940.000.00-0.017-0.0150.001
put6.000.002.150.002.8700.000.00-0.019-0.0160.001
put7.000.000.800.002.3130.000.00-0.024-0.0150.001
put8.000.002.150.051.9412.000.00-0.028-0.0150.001
put9.000.000.050.052.10612.000.00-0.085-0.0380.003
put10.000.000.050.051.6653000.00-0.106-0.0350.004
put11.000.000.100.051.2572460.00-0.136-0.0320.005
put12.000.000.200.100.9646920.00-0.170-0.0290.005
put13.000.050.350.250.7951,71088.00-0.349-0.0550.008
put14.000.400.850.800.8371,828469-0.536-0.0360.008
put15.000.003.501.552.3073900.00-0.751-0.0280.007
put16.002.202.752.551.4667.007.00-0.842-0.0250.005
put17.001.605.400.003.7770.000.00-0.935-0.0110.003
put18.002.556.404.474.0290.000.00-0.944-0.0120.002
put19.003.607.400.004.2730.000.00-0.950-0.0130.002
put20.004.608.406.054.5070.000.00-0.955-0.0130.002
put21.005.609.200.004.4260.000.00-0.958-0.0140.002
put22.006.6010.400.004.9360.000.00-0.961-0.0140.002
put25.009.6013.4010.355.4440.000.00-0.966-0.0150.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-26SEC
2026-10-21SCHEDULE 13D/ASEC
2026-09-166-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-16SEC
2026-08-116-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-11SEC
2026-08-05SCHEDULE 13D/ASEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-05SEC
2026-08-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-03SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-30SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-30SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-30SEC
2026-07-206-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-20SEC
2026-07-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-13SEC
2026-07-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-10SEC
2026-06-256-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-25SEC
2026-06-24SCHEDULE 13D/ASEC
2026-06-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-24SEC
2026-06-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-18SEC
2026-05-263Initial statement of beneficial ownership of securities2026-05-19SEC
2026-05-263Initial statement of beneficial ownership of securities2026-05-19SEC
2026-05-206-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-20SEC
2026-05-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-06SEC
2026-04-09SCHEDULE 13D/ASEC
2026-04-09SCHEDULE 13DSEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Doma Perpetual Capital Management LLC4.75%
ACADIAN ASSET MANAGEMENT LLC4.49%
BlackRock, Inc.4.34%
RENAISSANCE TECHNOLOGIES LLC4.16%
MENORA MIVTACHIM HOLDINGS LTD.3.55%
STEEL PARTNERS HOLDINGS L.P.3.18%
MILLENNIUM MANAGEMENT LLC3.05%
MORGAN STANLEY1.94%
SYSTEMATIC FINANCIAL MANAGEMENT LP1.77%
Jupiter Topco LLC1.68%

Funds

Fund% owned
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND2.29%
Janus Henderson Small Cap Value Fund1.68%
VANGUARD DEVELOPED MARKETS INDEX FUND1.54%
iShares Core MSCI EAFE ETF1.24%
JPMorgan Small Cap Blend Fund0.64%
Fidelity Series International Small Cap Fund0.63%
VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND0.60%
Old Westbury Small & Mid Cap Strategies Fund0.59%
iShares MSCI EAFE Small-Cap ETF0.58%
Fidelity International Small Cap Opportunities Fund0.43%

OakChart. INMD. Cached 15 minutes.

Some panels did not load: insider.